Joy Kong, MDRegenerative Medicine Physician, Educator, and Entrepreneur

The Cirrhosis Patient Modern Medicine Gave Up On

25 Jun 2026 · 1 min

Watch on YouTube

0:57

In this excerpt from a YouTube interview, Dr. Joy Kong recounts a striking clinical anecdote: a hospice‑level cirrhosis patient with massive ascites and an estimated 1‑2 month life expectancy received a single, low‑dose administration of an experimental cell therapy. Contrary to expectations, the patient’s abdominal swelling dramatically reduced during a trip from Los Angeles to Sacramento, he soon began walking and speaking normally, and within months his liver function tests returned to normal ranges. Dr. Kong emphasizes that conventional scientific studies have not yet caught up to such observations, highlighting the gap between existing research and real‑world outcomes of regenerative cell treatments for end‑stage liver disease.

Chapters

I don't care about the studies because the studies are not there. Science didn't catch up. What's your expert—
well, I've seen it do incredible things. One of my earliest patients was somebody that was dying from cirrhosis, literally in hospice care with, who knows, 1 to 2 months to be alive, and with huge ascites, so that's swelling the abdomen. And we did one treatment, actually at a fairly low dose. He didn't come back, and I didn't know what happened to him until a couple months later that his brother was on a radio show with me, and that's when I asked him, "How's your brother doing?" Because he was so weak, he barely could speak. What happened was, on the way back from Los Angeles to Sacramento, the swelling was halfway down. Within a few weeks, he was walking around in the yard, talking on the phone like he's some normal person. And then within months, his liver function was normal. I was so shocked. I did not expect that one small little dose of these cells could do this.